- Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
-
Kerbel RS
- KMID: 2166019
- Cancer Res Treat.
- 2007 Dec;39(4):150-159.
One of the most significant developments in medical oncology practice has been the approval of various antiangiogenic drugs for the treatment of a number of different malignancies. These drugs include... -
- CITED
-
- Close
- SHARE
-
- Close
